Loading…

Brentuximab vedotin and bendamustine as salvage therapy for primary refractory or relapsed Hodgkin lymphoma: A multicentre experience of the Polish lymphoma research group

Saved in:

Bibliographic Details
Published in:	Hematological oncology 2017-06, Vol.35 (S2), p.319-320
Main Authors:	Czyz, A., Lojko‐Dankowska, A., Rybka, J., Wrobel, T., Zaucha, J.M., Subocz, E., Balcerzak, A., Kroll‐Balcerzak, R., Joks, M., Komarnicki, M.
Format:	Article
Language:	English
Subjects:	Hodgkin's lymphoma Immunotherapy Lymphoma Monoclonal antibodies Salvage Targeted cancer therapy Therapy
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!